INS and metabolic dysfunction-associated steatohepatitis: MASH progressing to cirrhosis often coexists with type 2 diabetes mellitus (T2DM), a condition that exacerbates systemic inflammation, insulin resistance, and fibrogenesis—factors implicated in both hepatic and muscular deterioration.